Cargando…
Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771971/ https://www.ncbi.nlm.nih.gov/pubmed/26918364 http://dx.doi.org/10.1038/bcj.2016.8 |
| _version_ | 1782418479062712320 |
|---|---|
| author | Lu, A Fang, Y Du, X Li, Y Cai, Z Yu, K Zhao, L Wang, B Wu, J Cheng, Y Zuo, Y Jia, Y Tan, F Ding, L Lu, J Zhang, L Huang, X |
| author_facet | Lu, A Fang, Y Du, X Li, Y Cai, Z Yu, K Zhao, L Wang, B Wu, J Cheng, Y Zuo, Y Jia, Y Tan, F Ding, L Lu, J Zhang, L Huang, X |
| author_sort | Lu, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4771971 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47719712016-03-09 Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study Lu, A Fang, Y Du, X Li, Y Cai, Z Yu, K Zhao, L Wang, B Wu, J Cheng, Y Zuo, Y Jia, Y Tan, F Ding, L Lu, J Zhang, L Huang, X Blood Cancer J Letter to the Editor Nature Publishing Group 2016-02 2016-02-26 /pmc/articles/PMC4771971/ /pubmed/26918364 http://dx.doi.org/10.1038/bcj.2016.8 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Lu, A Fang, Y Du, X Li, Y Cai, Z Yu, K Zhao, L Wang, B Wu, J Cheng, Y Zuo, Y Jia, Y Tan, F Ding, L Lu, J Zhang, L Huang, X Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study |
| title | Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study |
| title_full | Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study |
| title_fullStr | Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study |
| title_full_unstemmed | Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study |
| title_short | Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study |
| title_sort | efficacy, safety and pharmacokinetics of clofarabine in chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase ii, multi-center study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771971/ https://www.ncbi.nlm.nih.gov/pubmed/26918364 http://dx.doi.org/10.1038/bcj.2016.8 |
| work_keys_str_mv | AT lua efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT fangy efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT dux efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT liy efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT caiz efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT yuk efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT zhaol efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT wangb efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT wuj efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT chengy efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT zuoy efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT jiay efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT tanf efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT dingl efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT luj efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT zhangl efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy AT huangx efficacysafetyandpharmacokineticsofclofarabineinchinesepediatricpatientswithrefractoryorrelapsedacutelymphoblasticleukemiaaphaseiimulticenterstudy |